Sign in

CIK 0001671502 · Non-accelerated filer<br>Smaller reporting company

Quoin Pharmaceuticals Ltd.

Sign in to watch
Ticker
QNRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
Incorporated
Israel
Entity type
operating
Phone
703 980 4182
Business address
42127 PLEASANT FOREST COURT, ASHBURN, VA, 20148-7349
Former names
Quoin Pharmaceuticals, Ltd., Cellect Biotechnology Ltd., Cellect Biomed Ltd.
Open-market buys, last 90 days
$279,966
in 4 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$279,966. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Carter Denise P. +$100K Chief Operating Officer 1 filing
  2. Myers Michael +$100K Chief Executive Officer 1 filing
  3. Lawlor Sally Bridget +$50K Chief Financial Officer 1 filing
  4. Culverwell Anthony James +$30K Director 1 filing
Date Insider Transaction Shares Price Value Owned after
2026-08-31 Carter Denise P. Chief Operating Officer Purchase +20,490 $4.88 $100K 37,709
2026-08-31 Carter Denise P. Chief Operating Officer Purchase · Ordinary Warrants (Right to Buy) +10,245 10,245
2026-08-31 Myers Michael Chief Executive Officer Purchase +20,490 $4.88 $100K 37,713
2026-08-31 Myers Michael Chief Executive Officer Purchase · Ordinary Warrants (Right to Buy) +10,245 10,245
2026-08-31 Lawlor Sally Bridget Chief Financial Officer Purchase +10,244 $4.88 $50K 10,684
2026-08-31 Lawlor Sally Bridget Chief Financial Officer Purchase · Ordinary Warrants (Right to Buy) +5,122 5,122
2026-08-31 Culverwell Anthony James Director Purchase +6,146 $4.88 $30K 40,364
2026-08-31 Culverwell Anthony James Director Purchase · Ordinary Warrants (Right to Buy) +3,073 3,073
2026-08-27 LANGER DENNIS Director Grant or award +34,534 $5.15 $178K 56,243
2026-08-27 Culverwell Anthony James Director Grant or award +31,352 $5.15 $161K 34,218
2026-02-04 Lawlor Sally Bridget Chief Financial Officer Grant or award · Share Option (Right to Buy) +85,250 85,250
2026-02-04 Cooper Joseph Patrick Director Grant or award · Share Option (Right to Buy) +8,141 8,141
2026-02-04 Culverwell Anthony James Director Grant or award · Share Option (Right to Buy) +21,709 21,709
2026-02-04 Myers Michael Chief Executive Officer Grant or award · Share Option (Right to Buy) +318,750 318,750
2026-02-04 Carter Denise P. Chief Operating Officer Grant or award · Share Option (Right to Buy) +318,750 318,750
2026-02-04 LANGER DENNIS Director Grant or award · Share Option (Right to Buy) +21,709 21,709
2026-02-04 SEMBER MICHAEL T Director Grant or award · Share Option (Right to Buy) +8,141 8,141
2026-02-04 Leong Natalie Ee Mun Director Grant or award · Share Option (Right to Buy) +12,211 12,211
2025-12-01 Lawlor Sally Bridget Chief Financial Officer Grant or award · Share Option (Right to Buy) +10,330 10,330
2025-10-14 LANGER DENNIS Director Purchase +15,152 $8.49 $129K 15,153

Page 1 of 4 · 78 trades